<DOC>
	<DOCNO>NCT02624063</DOCNO>
	<brief_summary>The purpose study study combination Sofosbuvir Combination With Daclatasvir Simeprevir 12 Weeks Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus ( HCV ) Genotype 1 .</brief_summary>
	<brief_title>Randomized Clinical Trial Sofosbuvir Combination With Daclatasvir Simeprevir 12 Weeks Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 ( TNT )</brief_title>
	<detailed_description>In open-label , single-center , head-to-head non-inferiority trial , treatment-naive pegylated interferon treatment-experienced patient GT1 infection randomize receive once-daily SOF 400 mg plus DCV 60 mg SIM 150 mg 12 week .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Genotype 1 HCV infection confirm positive test antiHCV antibody detectable serum HCV RNA PCR Never take DAAs HCV Patients must able understand agree to/comply prescribe dose regimen procedure , report regularly schedule study visit , reliably communicate study personnel adverse event concomitant medication No Liver Cirrhosis Liver fibrosis Metavir F3 APRI &gt; 1,5 FIB4 &gt; 3,25 Infection HCV GT1 subject mixed infection genotype Liver Cirrhosis Evidence decompensated liver Subjects Infected HIV1 Hepatitis B virus ( HBV ) coinfection Liver organ transplant ( include hematopoietic stem cell transplant ) cornea hair Current known history cancer Documented suspect hepatocellular carcinoma , evidence previously obtain image study liver biopsy Pregnancy impossibility use birth control method couple , breastfeed Regular use : erythromycin , clarithromycin , rifampicin , rifabutin , telithromycin , itraconazole , ketoconazole , posaconazole , fluconazole , voriconazole , dexamethasone , cisapride , rifapentine , carbamazepine , phenytoin , phenobarbital , oxcarbazepine , St. John 's wort ( Hypericum perforatum ) , silymarin ( Silybum marianum ) antiarrhythmic drug amiodarone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>